LEVEMIR

LOE Approaching

insulin detemir

BLAINJECTIONINJECTABLE
Approved
Oct 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT03960814N/ACompleted

A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

Started May 2019
12,847 enrolled
Diabetes Mellitus, Type 2
NCT03377699Phase 3Completed

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

Started Nov 2017
225 enrolled
DiabetesDiabetes Mellitus, Type 1
NCT02131272Phase 3Terminated

A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin

Started Jun 2014
42 enrolled
DiabetesDiabetes Mellitus, Type 2
NCT01835431Phase 3Completed

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Started Oct 2013
362 enrolled
DiabetesDiabetes Mellitus, Type 1
NCT01892319N/ACompleted

An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry

Started Sep 2013
2,446 enrolled
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2